Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

Sweep Dynamics (SD) plots: Computational identification of selective sweeps to monitor the adaptation of influenza A viruses.

Klingen TR, Reimering S, Loers J, Mooren K, Klawonn F, Krey T, Gabriel G, McHardy AC.

Sci Rep. 2018 Jan 10;8(1):373. doi: 10.1038/s41598-017-18791-z.

2.

A Portrait of the Sialyl Glycan Receptor Specificity of the H10 Influenza Virus Hemagglutinin-A Picture of an Avian Virus on the Verge of Becoming a Pandemic?

Schneider EK, Li J, Velkov T.

Vaccines (Basel). 2017 Dec 13;5(4). pii: E51. doi: 10.3390/vaccines5040051. Review.

3.

CK12a, a CCL19-like Chemokine That Orchestrates both Nasal and Systemic Antiviral Immune Responses in Rainbow Trout.

Sepahi A, Tacchi L, Casadei E, Takizawa F, LaPatra SE, Salinas I.

J Immunol. 2017 Dec 1;199(11):3900-3913. doi: 10.4049/jimmunol.1700757. Epub 2017 Oct 23.

PMID:
29061765
4.

Mutations Driving Airborne Transmission of A/H5N1 Virus in Mammals Cause Substantial Attenuation in Chickens only when combined.

Richard M, Herfst S, van den Brand JMA, de Meulder D, Lexmond P, Bestebroer TM, Fouchier RAM.

Sci Rep. 2017 Aug 3;7(1):7187. doi: 10.1038/s41598-017-07000-6.

5.

Mitogenic stimulation accelerates influenza-induced mortality by increasing susceptibility of alveolar type II cells to infection.

Nikolaidis NM, Noel JG, Pitstick LB, Gardner JC, Uehara Y, Wu H, Saito A, Lewnard KE, Liu H, White MR, Hartshorn KL, McCormack FX.

Proc Natl Acad Sci U S A. 2017 Aug 8;114(32):E6613-E6622. doi: 10.1073/pnas.1621172114. Epub 2017 Jul 24.

6.

The Interplay between the Host Receptor and Influenza Virus Hemagglutinin and Neuraminidase.

Byrd-Leotis L, Cummings RD, Steinhauer DA.

Int J Mol Sci. 2017 Jul 17;18(7). pii: E1541. doi: 10.3390/ijms18071541. Review.

7.

A Novel A(H7N2) Influenza Virus Isolated from a Veterinarian Caring for Cats in a New York City Animal Shelter Causes Mild Disease and Transmits Poorly in the Ferret Model.

Belser JA, Pulit-Penaloza JA, Sun X, Brock N, Pappas C, Creager HM, Zeng H, Tumpey TM, Maines TR.

J Virol. 2017 Jul 12;91(15). pii: e00672-17. doi: 10.1128/JVI.00672-17. Print 2017 Aug 1.

8.

Does influenza pandemic preparedness and mitigation require gain-of-function research?

Adam DC, Magee D, Bui CM, Scotch M, MacIntyre CR.

Influenza Other Respir Viruses. 2017 Jul;11(4):306-310. doi: 10.1111/irv.12458. Epub 2017 Jun 24.

9.

P2Y6 receptors are involved in mediating the effect of inactivated avian influenza virus H5N1 on IL-6 & CXCL8 mRNA expression in respiratory epithelium.

Huipao N, Borwornpinyo S, Wiboon-Ut S, Campbell CR, Lee IH, Hiranyachattada S, Sukasem C, Thitithanyanont A, Pholpramool C, Cook DI, Dinudom A.

PLoS One. 2017 May 11;12(5):e0176974. doi: 10.1371/journal.pone.0176974. eCollection 2017.

10.

Pathogenicity and transmission of a swine influenza A(H6N6) virus.

Sun H, Kaplan BS, Guan M, Zhang G, Ye J, Long LP, Blackmon S, Yang CK, Chiang MJ, Xie H, Zhao N, Cooley J, Smith DF, Liao M, Cardona C, Li L, Wang GP, Webby R, Wan XF.

Emerg Microbes Infect. 2017 Apr 12;6(4):e17. doi: 10.1038/emi.2017.3.

11.

Widespread Virus Replication in Alveoli Drives Acute Respiratory Distress Syndrome in Aerosolized H5N1 Influenza Infection of Macaques.

Wonderlich ER, Swan ZD, Bissel SJ, Hartman AL, Carney JP, O'Malley KJ, Obadan AO, Santos J, Walker R, Sturgeon TJ, Frye LJ Jr, Maiello P, Scanga CA, Bowling JD, Bouwer AL, Duangkhae PA, Wiley CA, Flynn JL, Wang J, Cole KS, Perez DR, Reed DS, Barratt-Boyes SM.

J Immunol. 2017 Feb 15;198(4):1616-1626. doi: 10.4049/jimmunol.1601770. Epub 2017 Jan 6.

12.

Viral factors in influenza pandemic risk assessment.

Lipsitch M, Barclay W, Raman R, Russell CJ, Belser JA, Cobey S, Kasson PM, Lloyd-Smith JO, Maurer-Stroh S, Riley S, Beauchemin CA, Bedford T, Friedrich TC, Handel A, Herfst S, Murcia PR, Roche B, Wilke CO, Russell CA.

Elife. 2016 Nov 11;5. pii: e18491. doi: 10.7554/eLife.18491.

13.

Probiotics for prevention and treatment of respiratory tract infections in children: A systematic review and meta-analysis of randomized controlled trials.

Wang Y, Li X, Ge T, Xiao Y, Liao Y, Cui Y, Zhang Y, Ho W, Yu G, Zhang T.

Medicine (Baltimore). 2016 Aug;95(31):e4509. doi: 10.1097/MD.0000000000004509. Review.

14.

Evolution of 2009 H1N1 influenza viruses during the pandemic correlates with increased viral pathogenicity and transmissibility in the ferret model.

Otte A, Marriott AC, Dreier C, Dove B, Mooren K, Klingen TR, Sauter M, Thompson KA, Bennett A, Klingel K, van Riel D, McHardy AC, Carroll MW, Gabriel G.

Sci Rep. 2016 Jun 24;6:28583. doi: 10.1038/srep28583.

15.

Human mesenchymal stromal cells reduce influenza A H5N1-associated acute lung injury in vitro and in vivo.

Chan MC, Kuok DI, Leung CY, Hui KP, Valkenburg SA, Lau EH, Nicholls JM, Fang X, Guan Y, Lee JW, Chan RW, Webster RG, Matthay MA, Peiris JS.

Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):3621-6. doi: 10.1073/pnas.1601911113. Epub 2016 Mar 14.

16.

Clinical, epidemiological and virological characteristics of the first detected human case of avian influenza A(H5N6) virus.

Zhang R, Chen T, Ou X, Liu R, Yang Y, Ye W, Chen J, Yao D, Sun B, Zhang X, Zhou J, Sun Y, Chen F, Wang SP.

Infect Genet Evol. 2016 Jun;40:236-42. doi: 10.1016/j.meegid.2016.03.010. Epub 2016 Mar 10.

17.

New England harbor seal H3N8 influenza virus retains avian-like receptor specificity.

Hussein IT, Krammer F, Ma E, Estrin M, Viswanathan K, Stebbins NW, Quinlan DS, Sasisekharan R, Runstadler J.

Sci Rep. 2016 Feb 18;6:21428. doi: 10.1038/srep21428.

18.

The Interaction between Respiratory Pathogens and Mucus.

Zanin M, Baviskar P, Webster R, Webby R.

Cell Host Microbe. 2016 Feb 10;19(2):159-68. doi: 10.1016/j.chom.2016.01.001. Review.

19.

Combined local and systemic immunization is essential for durable T-cell mediated heterosubtypic immunity against influenza A virus.

Uddback IE, Pedersen LM, Pedersen SR, Steffensen MA, Holst PJ, Thomsen AR, Christensen JP.

Sci Rep. 2016 Feb 1;6:20137. doi: 10.1038/srep20137.

20.

Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant.

Stavaru C, Onu A, Lupulescu E, Tucureanu C, Rasid O, Vlase E, Coman C, Caras I, Ghiorghisor A, Berbecila L, Tofan V, Bowen RA, Marlenee N, Hartwig A, Bielefeldt-Ohmann H, Baldwin SL, Van Hoeven N, Vedvick TS, Huynh C, O'Hara MK, Noah DL, Fox CB.

Hum Vaccin Immunother. 2016 Apr 2;12(4):1009-26. doi: 10.1080/21645515.2015.1111495. Epub 2015 Nov 30.

Supplemental Content

Support Center